|
Federal
Register Notices > Manufacturers 2008
>
AMRI Rensselaer, Inc.
FR Doc E8-11633[Federal Register: May 27, 2008 (Volume 73, Number 102)]
[Notices] [Page 30418-30419] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr27my08-89]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal Regulations
(CFR),
this is notice that on September 21, 2007, AMRI Rensselaer, Inc., 33 Riverside
Avenue, Rensselaer, New York 12144, made application by renewal to the Drug
Enforcement Administration (DEA) as a bulk manufacturer of the basic classes of
controlled substances listed in schedules I and II:
|
Drug
|
Schedule
|
|
Marihuana (7360)
|
I
|
|
Tetrahydrocannabinols (7370)
|
I
|
|
Amphetamine (1100)
|
II
|
|
Lisdexamfetamine (1205)
|
II
|
|
Methylphenidate (1724)
|
II
|
|
Pentobarbital (2270)
|
II
|
|
Hydrocodone (9193)
|
II
|
|
Meperidine (9230)
|
II
|
|
Dextropropoxyphene, bulk (non-dosage form)(9273)
|
II
|
|
Oxymorphone (9652)
|
II
|
|
Fentanyl (9801)
|
II
|
The company plans to manufacture bulk controlled substances for use in
product development and for distribution to its customers. In reference to drug
code 7360 (Marihuana), the company plans to bulk manufacture cannabidiol as a
synthetic intermediate. This controlled substance will be further synthesized to
bulk
[[Page 30419]]
manufacture a synthetic THC (7370). No other activity for this drug code is
authorized for this registration.
Any other such applicant, and any person who is presently registered with DEA
to manufacture such substances, may file comments or objections to the issuance
of the proposed registration pursuant to 21 CFR 1301.33(a).
Any such written comments or objections being sent via regular mail should be
addressed, in quintuplicate, to the Drug Enforcement Administration, Office of
Diversion Control, Federal Register Representative (ODL), Washington, DC 20537,
or any being sent via express mail should be sent to Drug Enforcement
Administration, Office of Diversion Control, Federal Register Representative (ODL),
8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later
than July 28, 2008.
Dated: May 19, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E8-11633 Filed 5-23-08; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|